加强基于ESC的TAA癌症疫苗的免疫反应,使用一种新的OMV传递系统
Meiling Jin1, Da Huo1, Jingjing Sun1
1Chinese Academy of Sciences (CAS) Key Laboratory of Quantitative Engineering Biology, Shenzhen Institutes of Advanced Technology, Shenzhen Institute of Synthetic Biology, Chinese Academy of Sciences, Shenzhen, China.
Journal of nanobiotechnology
|January 3, 2024
概括
工程化细菌外膜囊泡 (OMVs) 提供胚胎干细胞 (ESC) 衍生的瘤抗原和PD-L1抗体,增强CD8+ T细胞反应并减少小鼠的瘤生长.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 在瘤学瘤学.
背景情况:
- 胚胎干细胞 (ESC) 衍生的表位表现为癌症疫苗有前途,但患有免疫性差和CD8+ T细胞反应弱.
- 细菌外膜囊泡 (OMV) 是有效的免疫辅助剂和瘤抗原的传递载体.
研究的目的:
- 开发一个工程OMV平台,用于联合输送ESC衍生的瘤抗原 (TAA) 和PD-L1抗体,以增强抗瘤免疫力.
- 通过增强T细胞反应和增加抗原停留时间来提高基于ESC的癌症疫苗的疗效.
主要方法:
- 通过将SpyCatcher (SpC) 和Staphylococcal Protein A (SpA) 融合到OmpA.通过工程设计的细菌外膜囊泡 (OMVs).
- 开发了一个使用SpyTag-peptide和SPA-抗体相互作用的OMV与ESC衍生的TAA和抗PD-L1抗体的结合系统.
- 在小鼠瘤模型中评估了基于OMV的组合疗法的治疗疗效.
主要成果:
- 设计的OMV与TAA和PD-L1抗体有效结合,增加TAA的停留时间.
- 组合疗法显著抑制了小鼠的瘤生长.
- 治疗增强了IFN-γ产生CD8+ T细胞的反应,增加了CD8+记忆细胞,并增强了抗原特异性T细胞.
结论:
- 新的OMV平台使得ESC衍生的TAA和免疫检查点抑制剂能够有效地同时提供.
- 这种基于OMV的输送系统增强了抗瘤免疫反应,并有可能开发有效的癌症疫苗.
更多相关视频
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
1.8K
12:42Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.5K
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
